VC005 Placebo

DRUG2 trials

Sponsors

Jiangsu vcare pharmaceutical technology co., LTD

Conditions

Atopic Dermatitis

Phase 1

Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis

CompletedNCT06009094

Jiangsu vcare pharmaceutical technology co., LTDAtopic Dermatitis

Start: 2023-07-27End: 2024-05-23Updated: 2024-12-10

Phase 3

Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis

RecruitingNCT07592585

Jiangsu vcare pharmaceutical technology co., LTDAtopic Dermatitis

Start: 2026-05-12End: 2028-05-30Target: 360Updated: 2026-07-07